| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 08/11/2004 | CN1520395A Cycloalkenone derivative |
| 08/11/2004 | CN1520309A Methods and compsns. for treating oral and eosophagal lesions |
| 08/11/2004 | CN1520305A Compsns. for preparing external carbon dioxide agents |
| 08/11/2004 | CN1520303A Turnor therapy with alphavirus-based and high affinity laminin receptor-targeted vectors |
| 08/11/2004 | CN1520300A Dihydro-triterpenes in treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain |
| 08/11/2004 | CN1520298A Pyrazolopyrimidines as therapeutic agents |
| 08/11/2004 | CN1520291A Fumaric acid derivatives as NF-Kappab inhibitors |
| 08/11/2004 | CN1520290A Carbocyclic hydrorazino inhibitors of copper-containing amine oxidases |
| 08/11/2004 | CN1520283A Control of compactability through crystallization |
| 08/11/2004 | CN1520281A Compsn. for treatment of burns |
| 08/11/2004 | CN1519231A Coupling product between tryptamine and alpha-amino acid, process for its prepn. as well as its application in neurocosmetic field |
| 08/11/2004 | CN1519022A Gelling agent of stimulating factor of macrophage colony of recombined human granular leudocytes and preparation method |
| 08/11/2004 | CN1519019A Medicine for treating burns and scalds and preparation method |
| 08/11/2004 | CN1519015A Medication for treating hemorrhoids and preparation method |
| 08/11/2004 | CN1519011A Acne frost |
| 08/11/2004 | CN1519008A Externally applied agent for relieving inflammation and antibiosis |
| 08/11/2004 | CN1519003A Ointment for treating breach of skin |
| 08/11/2004 | CN1518994A Prescription of Chinese traditional medicine for relieving inflammation, detoxification and cancer prevention |
| 08/11/2004 | CN1518993A Vifiligo pill |
| 08/11/2004 | CN1518990A Soft capsule of fur seal oil and application in preparing health products for dispelling chloasma, whelk, cyasma |
| 08/11/2004 | CN1518988A Medication containing rare earth for treating skin disease and preparation method |
| 08/11/2004 | CN1518985A A group of medication compsn. for treating acne |
| 08/11/2004 | CN1161338C Fluorinated 3,4-dihydroquinoline derivatives used and NOS inhibitors |
| 08/11/2004 | CN1161141C Face-beatutifying sanility-delaying medcial wine for women and its preparing process |
| 08/11/2004 | CN1161139C External use traditional Chinese medicine preparation for curing scald by fire or water and its preparing method |
| 08/11/2004 | CN1161130C Composition for burn and scald |
| 08/11/2004 | CN1161128C Anigiogenic inhibitory compounds |
| 08/11/2004 | CN1161126C Composition for preparing medicines, beautifying and cosmetics and its application |
| 08/11/2004 | CN1161100C Topical compositions having improved skin feel |
| 08/11/2004 | CN1161099C Composition for topical delivery of active ingredients |
| 08/11/2004 | CN1161097C Method and composition for causing skin lightening |
| 08/11/2004 | CN1161021C Method of biological control |
| 08/10/2004 | US6774220 Compounds having lectinic properties and their biological applications |
| 08/10/2004 | US6774132 Spirooxindole derivatives that act as analgesics |
| 08/10/2004 | US6774127 Pyrazole and pyrazoline substituted compounds |
| 08/10/2004 | US6774121 Phospholipid prodrugs of anti-proliferative drugs |
| 08/10/2004 | US6774118 Therapeutic use of CIS-element decoys in vivo |
| 08/10/2004 | US6774114 Topical application of immixture of ascorbic acid + ascorbic acid compounds for augmenting the synthesis of epidermal ceramides |
| 08/10/2004 | US6774112 Antidiabetic agents; cardiovascular disorders |
| 08/10/2004 | US6774106 Methods and compositions of matter concerning APRIL/G70, BCMA, BLYS/AGP-3 and TACI |
| 08/10/2004 | US6774105 Methods of using latent TGF-β binding proteins |
| 08/10/2004 | US6773881 By modulating vascular endothelial growth factor (vegf) |
| 08/10/2004 | US6773708 Suppression of excessive th1 and stimulation of th2 cell mediated immune responses |
| 08/10/2004 | US6773703 Connected to polyethylene glycol via urea groups; healing therapy resistant wounds |
| 08/10/2004 | US6773701 Expression enhancer for protein synthesis inhibitory genes |
| 08/10/2004 | CA2315266C Wound healing compositions |
| 08/10/2004 | CA2255661C Antiangiogenic drug to treat cancer, arthritis and retinopathy |
| 08/10/2004 | CA2136238C Renewal of extrinsic aging of the skin by transdermal application of selenoamino acids |
| 08/05/2004 | WO2004065400A1 Novel binding epitopes for helicobacter pylori and use thereof |
| 08/05/2004 | WO2004065372A1 Tetrazole-functionalized amino acids, their production and use |
| 08/05/2004 | WO2004065345A1 5,6,7,8-tetrahydronaphthalen-2-yl 2,6-difluoroheptatrienoic acid derivatives having serum glucose reducing activity |
| 08/05/2004 | WO2004064833A1 Clindamycin phosphate foam |
| 08/05/2004 | WO2004064827A1 Use of porphyrin synthesis substances for carrying out phototherapy and for curing skin and articulation diseases |
| 08/05/2004 | WO2004064743A2 Modified retinoid compounds and their uses |
| 08/05/2004 | WO2004064716A2 Eicosapentaenoic acid and docosapentaenoic acid for treating inflammatory disorders |
| 08/05/2004 | WO2004064668A2 Horse shoe and medical composition |
| 08/05/2004 | WO2004024077A9 Novel composition and methods for the treatment of psoriasis |
| 08/05/2004 | WO2004022716A9 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 08/05/2004 | WO2004010974A3 Gelatin capsule exhibiting reduced cross-linking |
| 08/05/2004 | WO2004010973A3 Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage |
| 08/05/2004 | WO2003103590A3 (halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents |
| 08/05/2004 | WO2003070204A3 Lipase inhibiting composition |
| 08/05/2004 | WO2002090552A3 Use of 2'-5'-oligoadenylate synthetase and/or rnasel or nucleic acids encoding them for diagnosis, prophylaxis or treatment of wound healing |
| 08/05/2004 | US20040152892 Oxazolo-and furopyrimidines and their use in medicaments against tumors |
| 08/05/2004 | US20040152779 Bicyclic amino acids as pharmaceutical agents |
| 08/05/2004 | US20040152772 1-butyric acid derivatives and the use thereof |
| 08/05/2004 | US20040152768 NO-synthase inhibitors comprising ascorbyl 2-hexadecanoate |
| 08/05/2004 | US20040152761 Dimeric isoflavones |
| 08/05/2004 | US20040152754 Cyclic AMP-specific phosphodiesterase inhibitors |
| 08/05/2004 | US20040152753 Methods of use for novel sulfur containing organic nitrate compounds |
| 08/05/2004 | US20040152746 Treatment of scarring and related conditions using ppar-gamma activators |
| 08/05/2004 | US20040152738 Wound healing agents; antiarthritic agents; osteoporosis; congestive heart failure; antiulcer agents; Alzheimer's disease; anticholesterol agents; antiarthritic agents |
| 08/05/2004 | US20040152735 NO-synthase inhibitors comprising N,N'-bis(2-pyridyl)methyl-N,N'-bis(3,4,5-trimethoxybenzyl) ethylenediamine |
| 08/05/2004 | US20040152734 Substituted C-furan-2-yl-methylamine and C-thiophen-2-yl-methylamine compounds |
| 08/05/2004 | US20040152730 Novel compounds |
| 08/05/2004 | US20040152726 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 08/05/2004 | US20040152680 Treating autoimmune diseases, skin disorders, malignancies |
| 08/05/2004 | US20040152679 (20S)-1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses |
| 08/05/2004 | US20040152678 Administering 20S)-1 alpha -hydroxy-2 alpha -methyl-19-nor-vitamin D3 for therapy of psoriasis |
| 08/05/2004 | US20040152677 (20S)-1alpha-hydroxy-2alpha-methl and 2beta-methyl-19-nor-vitamin D3 and their uses |
| 08/05/2004 | US20040152676 (20S)-1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses |
| 08/05/2004 | US20040152675 (20S)-1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses |
| 08/05/2004 | US20040152668 Vitamin d receptor antagonists and related compositions and methods of use |
| 08/05/2004 | US20040152652 Therapy of inflammatory disorder in an individual comprising administering oligonucleotide up to 30 nucleotides in length complementary to a nucleic acid molecule encoding human tumor necrosis factor- alpha |
| 08/05/2004 | US20040152636 For therapy of diseases or disorders characterized by undesirable excessive vascularization such as tumors, rheumatoid arthritis, psoriasis, atherosclerosis, diabetic and other retinopathies, retrolental fibroplasia, macular degeneration |
| 08/05/2004 | US20040152191 Using activator glycoprotein to propagate activated macrophages or dendritic cells from monocytes or hematopoietic stem cells for use in treatment of allergic, cell proliferative, autoimmune and infectious disorders |
| 08/05/2004 | US20040152157 G-protein coupled receptors |
| 08/05/2004 | US20040152123 for drug screening enzyme inhibitors for cancer treatments; biochips; genetic engineering |
| 08/05/2004 | US20040152078 Genetic engineering |
| 08/05/2004 | US20040151793 Onion extract can be integrated into base containing oil without effectiveness being reduced or phase separation being produced |
| 08/05/2004 | US20040151786 Pharmaceutical and/or cosmetic compositions for the treatment of localised adiposities and cellulite |
| 08/05/2004 | US20040151726 Novel vaccine for prophylaxis and theraphy in vetirinary and human medicine |
| 08/05/2004 | US20040151713 Cell cycle regulatory factor |
| 08/05/2004 | US20040151671 Topical applying; pressurized container with alcohol foaming agents; acne therapy |
| 08/05/2004 | CA2518754A1 5,6,7,8-tetrahydronaphthalen-2-yl 2,6-difluoroheptatrienoic acid derivatives having serum glucose reducing activity |
| 08/04/2004 | EP1443110A2 Human VEGF-specific antisense oligonucleotides |
| 08/04/2004 | EP1443108A2 Processes for preparing reconstructed skin supplemented in ceramid 7 and/or 5.5, composition based on lamellar lipid vesicles comprising a derivative of ceramid 7 and/or 5.5 and use thereof |
| 08/04/2004 | EP1443106A1 Somatic cell derived embryonic stem cells and its differentiated cells |
| 08/04/2004 | EP1443046A1 Novel 4-(2furoyl)aminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same |
| 08/04/2004 | EP1442740A1 Use of N-arylmethylene ethylenediamine triacetates, N-arylmethylene iminodiacetates or N, N'-diarylmethylene ethylenediamine diacetates as NO donors |